TMEM88 and lung carcinoma: Kaplan-Meier survival analysis showed that the overall survival of lung cancer patients (38.8 ± 4.83 months) with high TMEM88 expression was significantly lower than that of patients (58.64 ± 4.24 months) with low TMEM88 expression (26).